Skip to main content
Top
Published in: Obesity Surgery 8/2021

01-08-2021 | Bariatric Surgery | Letter to the Editor

Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use

Authors: Erica A. Amianda, Thomas S. Gavigan, Toghrul Talishinskiy, Douglas R. Ewing, Hans J. Schmidt

Published in: Obesity Surgery | Issue 8/2021

Login to get access

Excerpt

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were FDA approved in 2013 as an adjunct to glucophage for type 2 diabetes mellitus (T2DM). They are commonly utilized in patients with obesity because they also lower blood pressure, have weight loss benefits and cardiovascular disease benefits. Euglycemic diabetic ketoacidosis (EDKA) is a known adverse effect of this medication, and decreased intake after bariatric surgery (BS) increases that risk. We describe two cases of patients who stopped their SGLT2i as instructed prior to BS and developed severe EDKA requiring hospitalization. …
Literature
1.
go back to reference Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 30, 2020. Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 30, 2020.
3.
go back to reference Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175–247.CrossRef Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175–247.CrossRef
4.
go back to reference Suhl E, Anderson-Haynes SE, Mulla C, et al. Medical nutrition therapy for post-bariatric hypoglycemia: practical insights. Surg Obes Relat Dis. 2017;13(5):888–96.CrossRef Suhl E, Anderson-Haynes SE, Mulla C, et al. Medical nutrition therapy for post-bariatric hypoglycemia: practical insights. Surg Obes Relat Dis. 2017;13(5):888–96.CrossRef
5.
go back to reference Song R, Cao S. Post-bariatric surgery starvation ketoacidosis and lipase elevation in the absence of DKA or pancreatitis. Am J Emerg Med. 2018;36(3):525.e3-525.e5. Song R, Cao S. Post-bariatric surgery starvation ketoacidosis and lipase elevation in the absence of DKA or pancreatitis. Am J Emerg Med. 2018;36(3):525.e3-525.e5.
6.
go back to reference Membership of the Working Party, Barker P, Creasey PE, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland [published correction appears in Anaesthesia. 2019 Jun;74(6):810]. Anaesthesia. 2015;70(12):1427-1440. Membership of the Working Party, Barker P, Creasey PE, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland [published correction appears in Anaesthesia. 2019 Jun;74(6):810]. Anaesthesia. 2015;70(12):1427-1440.
7.
go back to reference Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of sglt-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753–62.CrossRef Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of sglt-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753–62.CrossRef
8.
go back to reference Mulla CM, Baloch HM, Hafida S. Management of diabetes in patients undergoing bariatric surgery. Curr Diab Rep. 2019;19(11):112.CrossRef Mulla CM, Baloch HM, Hafida S. Management of diabetes in patients undergoing bariatric surgery. Curr Diab Rep. 2019;19(11):112.CrossRef
9.
go back to reference Jardiance (empagliflozin) [package insert]. Ingelheim, Germany:Boehringer Ingelheim Pharmaceuticals, Inc; 2020. Jardiance (empagliflozin) [package insert]. Ingelheim, Germany:Boehringer Ingelheim Pharmaceuticals, Inc; 2020.
10.
go back to reference Invokana (canagliflozin) [package insert]. Titusville, NJ: Janssen Pharmaceutical Companies; 2020. Invokana (canagliflozin) [package insert]. Titusville, NJ: Janssen Pharmaceutical Companies; 2020.
11.
go back to reference Farxiga (dapagliflozin) [package insert]. Wilmington, DE: AstraZeneca Pharmaceutical LP; 2020. Farxiga (dapagliflozin) [package insert]. Wilmington, DE: AstraZeneca Pharmaceutical LP; 2020.
Metadata
Title
Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use
Authors
Erica A. Amianda
Thomas S. Gavigan
Toghrul Talishinskiy
Douglas R. Ewing
Hans J. Schmidt
Publication date
01-08-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05391-0

Other articles of this Issue 8/2021

Obesity Surgery 8/2021 Go to the issue